SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 93.48+1.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3138)6/8/2017 10:14:20 PM
From: Miljenko Zuanic  Read Replies (1) of 3202
 
<So, I get what MZ and AF are saying. Indoximod seems to work by by targeting an indirect effect of IDO,...>
Correct, and at 200-2000 mg dose it is more like supplement that enzyme inhibitor. I have no idea how Roche give away $150M for this "krap"?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext